Announcing a new article publication for BIO Integration journal. Cardiac cell death and myocardial fibrosis after ischemia-reperfusion (I/R) injury are the primary causes of impaired cardiac function ...

Injecting infarcted pig hearts with specially bioengineered cells significantly decreased the infarct area and improved heart function, showing possible clinical relevance “It is widely acknowledged ...

Reintroduction of the Cyclin A2 gene enables adult human cardiomyocytes to divide, producing functional daughter cells and promoting heart repair. The therapy uses a replication-deficient adenoviral ...

Developmental origin and subtype function of cardiac macrophages. Embryonic development (E7.5-E12.5) revolves around the hematopoietic endothelium (HE) of the yolk sac (YS), which undergoes three ...

On Tuesday, April 7, the Department of Chemistry welcomed Herdeline Ann "Digs" Ardoña from the University of California, ...

Myocardial infarction research reveals immune-driven cardiac damage. Learn how targeting NK cells could improve heart ...

The discovery of a novel approach to promote cardiomyocyte proliferation offers new hope for the treatment of ischemic heart failure. Researchers in the Michael E. DeBakey Department of Surgery at ...

Study reveals how an RNA enzyme drives the postnatal switch from glucose to fatty acids in heart cells, highlighting ketogenesis as essential for metabolism. Study: The tRNA methyltransferase Mettl1 ...

In research, induced pluripotent stem (iPS) cells are derived from skin, urine, or blood samples and developed into other cells, like heart tissue, that researchers want to study. Because of the ...

Japan's Central Social Insurance Medical Council on Wednesday started to discuss extending the public health insurance coverage to two regenerative medicine products using induced pluripotent stem, or ...